In studies involving non-small cell lung cancer (NSCLC) and GBM, GRP78 antibodies exert a significant tumor-suppressive effect both in vitro and in vivo, particularly when combined with ionizing radiation [115]. This evidence concerns the gene HSPA5 and non-small cell lung carcinoma.